JPRN-UMIN000008191已完成4 期
Examination for the effect of combination therapy with Eldecalcitol and Alendronate in primary osteoporotic patients - Examination for the effect of combination therapy with Eldecalcitol and Alendronate in primary osteoporotic patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are diagnosed as contraindication of Alendronate treatments 2. Patients who are diagnosed as contraindication of Eldecalcitol treatments 3.Patients who have taken osteoporosis treatments other than Alendronate 4.Patients with cancer 5. Patients who are inappropriate for this study by physician
研究者
相似试验
招募中
不适用
Examination for the effect of combination therapy with raloxifene and eldecalcitol in primary osteoporotic patients -Switch from alfacalcidol to eldecalcitolOsteoporosisJPRN-UMIN000007742Kyorin University120
已完成
不适用
Examination for the effect of combination therapy with raloxifene and eldecalcitol in postmenopausal osteoporotic patientsOsteoporosisJPRN-UMIN000008440Kurume University, Medical Department70
已完成
不适用
Examination for the effect of combination therapy with alendronate and eldecalcitol in primary osteoporotic patients :A randomized active comparator study -Switch from alfacalcidol to eldecalcitolOsteoporosisJPRN-UMIN000006964Tokyo Women's Medical University Medical Center East120
招募中
不适用
Examination for the effect of combination therapy using SERM and Eldecalcitol for the patients with osteoporosisOsteoporosisJPRN-UMIN000006027Department of Medicine for Motor Organ, Juntendo University Graduate School of Medicine150
尚未招募
不适用
The study about the effect of combination therapy of active form of vitamin D and lanthanum carbonate for serum concentration of FGF23chronic kidney diseaseJPRN-UMIN000030503Fujita Health University100